Jonathan Mahler, Columnist

Baseball's Bountygate Moment

Major League Baseball may be on the brink of handing down itsÂ largest group of suspensionssince the infamous 1919 Black Sox Scandal. It also may on the brink of its own version of football'sÂ Bountygate.

June 5, 2013 at 3:58 PM UTC

By Jonathan Mahler

Jonathan Mahler is a sports columnist for Bloomberg View. He is the author of the best-selling "Ladies and Gentlemen, the Bronx Is Burning," the basis for the eight-part ESPN mini-series. He also wrote "The Challenge," the winner of the 2009 Scribes Book Award, and "Death Comes to Happy Valley." A longtime contributor to the New York Times Magazine and the Times Book Review, Mahler has written for numerous other publications including the Washington Post, Slate, the New Republic and New York magazine. He lives in New York.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Major League Baseball may be on the brink of handing down itslargest group of suspensions since the infamous 1919 Black Sox Scandal. It also may be on the brink of its own version of football's Bountygate.

Baseball's latest performance-enhancing-drug scandal has its roots in a Miami New Times story published this year about the Biogenesis of America anti-aging clinic in South Florida, which allegedly provided human growth hormone and other banned drugs to a number of major leaguers. There was even a paper trail, including a hand-scrawled list linking a couple of baseball's biggest names -- Alex Rodriguez of the New York Yankees and Ryan Braun of the Milwaukee Brewers -- to the head of the clinic, Tony Bosch.